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Abstract
Objective To retrospectively compare the accuracy of the
initial MRI (magnetic resonance imaging) report of referring
radiologists and the second opinion report.
Material and methods MRI of 155 patients presenting with a
soft tissue tumor (STT) in a single large community center
were referred for inclusion in the Belgian Soft Tissue Neo-
plasm Registry (BSTNR). The initial report and the second
opinionreportweremadeindependently.Histopathology(gold
standard) was obtained in 90 patients (group 1). In 65 patients,
thediagnosiswasmadebythecombinationofclinicalfindings
and/or follow-up (group 2). In group 1, the concordance in
grading and tissue-specific (TS) diagnosis between the refer-
ring center (RC) and expert center (EC) was reviewed.
Results In group 1, MR grading yields a sensitivity of 100%
and a specificity of 89% in the EC. The sensitivity was 88%
and the specificity 81% in the RC. The accuracy was sig-
nificantly higher in the EC (92%) compared to the RC
(83%) (p00.039). The TS diagnosis was correct in 50%
versus 38.5% of malignant tumors and in 71.8% versus
51.6% of benign tumors in the EC and RC respectively.
Conclusion A second opinion report increases the accuracy
in the diagnosis of STT on MRI.
Main Messages
￿ A second opinion MRI report increases the overall accu-
racy in the diagnosis of soft tissue tumors.
￿ There is a good overall agreement in MR grading between
the referring and expert institution.
￿ In the expert center, there were fewer false-negative and
false-positive diagnoses.
￿ MRI performs better in the tissue-specific diagnosis of
benign versus malignant STT.
Keywords Softtissue tumors.Magneticresonanceimaging.
Histopathology.Secondopinion.Retrospectivestudy
Introduction
Soft tissue tumors (STT) consist of a heterogeneous group
of tumors with a variable biological behavior and prognosis.
Correct diagnosis is essential for accurate determination of
prognosis and to guide appropriate treatment strategy. The
added value of an expert second opinion report of soft tissue
tumor specimens has been emphasized previously in the
pathology and orthopedic literature[1–4]. Although magnetic
resonance imaging (MRI) is considered to be a useful tech-
nique for local staging, grading and characterization of STT
[5, 6], previous studies regarding the value of MRI in
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accuracy based on the analysis of different parameters in one
single institution with large expertise in the subject [5, 7–9].
The Belgian Soft Tissue Neoplasm Registry (BSTNR) is a
multi-institutional database project involving the cooperation
of a large number of MRI centers in Belgium. The initiative
started back in 2001 and had two main goals: firstly, to
provide a second opinion report within 48 h as a professional
courtesy toward the cooperating radiologists; secondly, to
serve as a scientific database of STTs, which are rare lesions
indaily radiologicalpractice [10]. Currently, 2,377 cases have
been included in the database. The purpose of the current
study is to compare the diagnostic accuracy of MR imaging
in grading and characterization of soft tissue tumors (STT) of
the initial report made by the referring radiologist in a large
community hospital and the second opinion report made by
the experts of the BSTNR.
Materials and methods
During a 10-year period (April 2001-April 2011), MR imaging
examinations of 155 patients presenting with a STT in a single
large community center were referred for inclusion in the
Belgian Soft Tissue Neoplasm Registry (BSTNR) and a sub-
sequent second opinion MR report. All examinations were
performed on a 1.5-T MR scanner (General Electric, Signa,
Milwaukee, WI, USA). The MR study protocol consisted of
axial T1-weighted images (WI), axial T2-WI, axial fat
suppressed (FS) T1-WI, coronal or sagittal FS T2-WI depend-
ing onthelesion location, axial FS contrast-enhanced (CE)T1-
WI, coronal or sagittal FS CE T1-WI, and subtraction of axial
pre- and post-CE FS T1-WI. Intravenous administration of
gadolinium contrast was not performed in cases where the
imaging diagnosis was already made on the noncontrast-
enhanced MRI scan. The report from the referring radiologist
was made by a single general radiologist (either K.T. or J.D.),
bothhavingexperienceinMRI(12and14years,respectively).
The expert report was made in consensus by a panel of at least
two musculoskeletal radiologists experienced in imaging of
STT (A.D.S., 25 years of experience; J.G. and F.V., each
20 years of experience). Age, gender and clinical information
were available, but the experts were blinded to the initial
Table 1 Parameter analysis in the second opinion report
Second opinion report parameters
￿ Age
￿ Gender
￿ Location
￿ Volume
￿ Margins
￿ Intra- versus extracompartmental extension
￿ Multiplicity
￿ Presence of intralesional calcifications
￿ Morphological signs (fluid-fluid levels, target sign,
fascicular sign, bunch of grapes, etc.)
￿ Signal intensity on different pulse sequences
￿ Inhomogeneity
￿ Intralesional hemorraghe
￿ Intralesional necrosis
￿ Degree (none, moderate or marked?) and pattern of enhancement
(central versus peripheral with papillary projections?) on static
contrast examination
￿ Contrast kinetics (if available) on dynamic contrast examination
￿ Invasion of adjacent bones and neurovascular bundles
Fig. 1 a-b B-cell non-Hodgkin’s lymphoma of the forearm abutting
the fascia. a Axial spin-echo T1-WI. Fusiform subcutaneous mass
(black arrows) extending along the superficial fascia. The lesion is of
slightly higher SI compared to the SI of muscle. b Sagittal STIR image.
The lesion is of intermediate signal intensity. Note surrounding strand-
ing (white arrows) of the subcutaneous fat (lymphangitis)
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analysis of individual parameters described in the literature
(Table 1)[5, 6]. The revised nomenclature proposed by the
World Health Organization was used [11]. MR grading is
defined as differentiation between benign and malignant
lesions, whereas characterization on MR consists of prediction
of the exact histology (tissue-specific diagnosis). The age of
the patients ranged between 6 months and 88 years. Histopa-
thology, which was used as the gold standard, was obtained in
90 cases (group 1). In 65 patients, the diagnosis was made by
thecombinationofclinicalfindingsand/orfollow-up(group2).
In group 1, the concordance in differentiation between benign
and malignant tumors and tissue-specific (TS) imaging diag-
nosis between the referring center and expert center was deter-
mined. Four categories were distinguished on MRI:
& correct diagnosis both by the referring center and second
opinion report
& incorrect diagnosis by the referring center; correct second
opinion report
& correct diagnosis by the referring center; incorrect second
opinion report
& incorrect diagnosis by both the referring center and
second opinion report
If multiple differential diagnoses were suggested in the
radiological reports, only the first (most probable) diagnosis
was taken into account. Indeterminate lesions with high
suspicion of malignancy were considered as malignant.
Group 2 was divided into two categories:
& Concordant diagnosis between the referring center and
second opinion report
& Discordant diagnosis between the referring center and
second opinion report
For group 1, sensitivity, specificity and accuracy of MR
grading were calculated for the referring center reports and
second opinion reports. The performance of the referring
center reports and second opinion reports were compared by
means of McNemar tests. To assess the agreement between
the referring center and second opinion reports on all 155
lesions (with or without histological proof), Cohen’s kappa
coefficient was calculated. All statistical analyses were per-
formed by the Statistical Package for the Social Sciences
(SPSS) 19 software (IBM, New York, USA)
Results
Group 1
Group 1 revealed 26 malignant lesions and 64 benign
lesions.
Malignant lesions
In 23 cases, the lesion was scored as malignant by the
referring center (RC) and the expert center (EC). In three
cases, the imaging diagnosis of a benign lesion was made by
the RC, whereas the EC made the imaging diagnosis of a
malignant lesion (correct grading of 100% versus 88.5% in
EC versus RC respectively). One lesion consisted of a soft
tissue lymphoma (Fig. 1), incorrectly diagnosed by the
referring center as a schwannoma. The other lesions with
discordant imaging diagnosis were myxofibrosarcoma (vs.
rhabdomyoma) and leiomyosarcoma (vs. nodular fasciitis).
A correct tissue-specific (TS) diagnosis was made by
both the RC and the EC in eight cases. In eight cases, there
was disagreement in the TS diagnosis between the referring
center and the expert center (5 cases of correct diagnosis in
an expert center and 3 cases of correct diagnosis in the
referring center). TS diagnosis was incorrect in both centers
in ten cases (Table 2). The TS diagnosis was correct in 13/26
Table 2 Categories of tissue-specific MR diagnosis of histologically
proven malignant tumors (n026)
Histology Number
a. Correct diagnosis both by referring center and second opinion report
Lymphoma 2
Well-differentiated liposarcoma 2
Soft tissue metastasis 2
Sarcoma NOS 1
Pleiomorphic liposarcoma 1
Total 8
b. Incorrect diagnosis by referring center; correct second opinion report
Lymphoma 1
Myxoid sarcoma 1
Sarcoma NOS 1
Chondrosarcoma 1
Low-grade myxofibrosarcoma 1
Total 5
c. Correct diagnosis by referring center; incorrect second opinion
report
Leiomyosarcoma 1
Chondrosarcoma 1
Pleiomorphic sarcoma 1
Total 3
d. Incorrect diagnosis both by referring center and second opinion
report
Sarcoma NOS 4
Myxoid liposarcoma 2
Leiomyosarcoma 2
Spinocellular leiomyosarcoma 1
Synovial sarcoma 1
Total 10
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(38.5%) in the referring institution.
Benign lesions
In 50 cases, the lesion was scored as benign by both centers.
In seven cases, a correct diagnosis of a benign lesion was
made by the expert center, whereas the referring center
made the diagnosis of a malignant lesion. In two cases, an
incorrect diagnosis of a malignant lesion was made by the
expert center, whereas the referring center made the diagno-
sis of a benign lesion. In five benign lesions, the imaging
diagnosis was malignant in both centers.
A correct TS diagnosis was made by both the referring
center and the expert center in 31 cases (48.4%). In 17 cases,
there was discordance in the TS diagnosis (Figs. 2 and 3)
between the referring center and the expert center (15 cases
of correct diagnosis in the expert center and two cases of
correct diagnosis in the referring center). The TS diagnosis
was incorrect in both centers in 16 cases (Table 3). The TS
diagnosis was correct in 46/64 benign lesions (71.8%) in the
expert center versus 33/64 (51.6%) in the referring
institution.
For histologically proven lesions (group 1), a sensitivity
of 100% vs. 88% (p00.250), a specificity of 89% vs. 81%
(p00.180) and accuracy of 92 vs. 83% (p00.039 ) (McNemar
test) were obtained for grading in the expert center vs. the
referring institution respectively (Table 4).
Group 2
Group 2 comprised 65 lesions in which the diagnosis was
madebythe combination ofclinicalfindingsand/orfollow-up
without histopathological proof as the gold standard. Most
lesions were considered as benign,andtherefore a wait-and-see
policy was preferred by the referring clinicians. In 51 cases,
there was concordance in the TS diagnosis between the refer-
ring center and the expert center. These cases are summarized
in Table 5. There was disagreement about the diagnosis in 14
cases. Twelve of the latter cases were scored as benign by both
institutions, whereas suspicion of malignancy was raised by the
referring center in one case and by the expert center in another
Fig. 2 a-c Pigmented villonodular synovitis in a 31-year-old man,
misdiagnosed as a malignant lesion by the referring institution. a Axial
SE T1-WI. Lobulated intra-articular lesion at the left metatarsophalan-
geal joint of the hallux (black arrows). Note the presence of erosions on
both sides of the joint (black arrowheads). The lesion is of overall low
signal. b Axial TSE T2-WI. The lesion is still of very low signal (black
arrows). c Axial fat suppressed SE T1-WI after IV administration of
gadolinium contrast. Marked enhancement of the lesion (black arrows).
Despite the aggressive behavior of the lesion (erosions), the low signal
of the lesion on both pulse sequences (in keeping with hemosiderin
deposition), the articular location of the lesion, the marked enhance-
ment and the relatively young age of the patient allowed a correct
tissue-specific diagnosis by the expert center
134 Insights Imaging (2012) 3:131–138case. Because of the clinical evidence of benignity, no further
diagnosticortherapeuticactionwasundertakenbythereferring
clinician.
All lesions
As far as the differentiation between benign and malignant
STT is concerned, there is good overall agreement (Table 6)
between both institutions (Cohen’s kappa00.742).
Discussion
Since its introduction to clinical imaging more than 2 decades
ago, MRI has radically modified the practice of preoperative
assessment of STT. The accuracy of this technique in grading
and characterization was studied in many previous papers
[5–9]. The reported results were however based on analysis
of MRI examinations by groups of dedicated musculoskeletal
(MSK) radiologists in single institutions with a great deal of
expertise in the subject. As MRI has become a widespread
technique, performed in many general hospitals, the current
study aimed to compare the accuracy of MRI reports made by
radiologists in community hospitals and second opinion
reports made by experts in MSK radiology.
In our series, the overall agreement in MR grading of STT
(including both histological and nonhistological confirmed
cases) between EC and RC is good. This may reflect adequate
core knowledge of the referring radiologists regarding MR
diagnosis of STT. On the one hand, this may be due to the high
level of general radiological education in our country. On the
otherhand,continuingeducationandevaluationoffeedbackby
reading the second opinion report may have contributed to this
good overall agreement. Furthermore, evolving experience in
the imaging diagnosis of STT may also have resulted in an
improved diagnosis in the EC. Unfortunately, because of the
relatively low number of referred cases/year, quantification and
statistical analysis of the learning curves of both institutions are
not possible.
However, despite the good overall agreement, there
were some significant differences in grading between the
RC and EC.
In the EC, there were no false negatives (misdiagnosis of a
malignant tumor as a benign lesion), compared to a minority
of malignant tumors misdiagnosed on MRI as benign tumors
in the RC.
Fig. 3 a-c Diffuse plexiform neurofibroma of the thigh. a Axial SE T1-
WI. Diffuse infiltrating mass lesion in the popliteal fossa causing scallop-
ing (black arrows) of the posterior cortex of the left femur. b Sagittal fat-
suppressed TSE proton density WI. The lesion is of high signal (white
arrows). c Axial fat-suppressed SE T1-WI after IV administration of
gadolinium contrast. Diffuse enhancement of the lesion (white arrows).
Although a rare occurrence, a plexiform neurofibroma may present as a
diffuse infiltrating mass causing pressure erosion of the adjacent bone.
Experience with a large series of rare pathology allowed the expert center
to suggest a correct tissue-specific diagnosis
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tion of multiple parameters, experience with a larger series
of STT and knowledge of sometimes subtle imaging signs
may have contributed to this better prediction of malignancy
in the EC. A typical example consisted of a soft tissue
lymphoma, incorrectly diagnosed by the referring center as
a schwannoma, mainly because of its fusiform morphology.
Although the MR appearance of soft tissue lymphoma may
be nonspecific in most cases [12], certain useful signs have
been reported previously. Most ST lymphomas are of hy-
perintense signal on T2-weighted images, but a relatively
low to intermediate signal on T2-weighted images may be
seen as well [13, 14]. Other potential useful signs in the MR
diagnosis of ST lymphoma are the homogeneity of the
lesion on all pulse sequences and the absence of central
necrosis in relatively large tumors [14], the growth pattern
along the fascia [15], surrounding lymphangitis and the
“wrapped-around” sign of lymphoma surrounding bony
structures [16, 17]. False negatives may have a major impact
on patient management and the ultimate prognosis. This
underscores the value of a second opinion MR report. In
our series, false-positive diagnoses (misdiagnosis of a be-
nign tumor as a malignant lesion) were less frequent in the
EC compared to the RC, which may reduce the number of
unnecessary biopsies. The impact of a false-positive imag-
ing diagnosis is less pronounced as this will not result in
radical modification of the treatment strategy. However,
Table 3 Categories of tissue-specific MR diagnosis of histologically
proven benign tumors (n064)
Histology Number
a. Correct diagnosis both by referring center and second opinion report
Lipoma 7
Neurogenic tumor 5
Giant cell tumor 4
Morton’s fibroma 4
Hemangioma 4
Tumor-like lesion 3
Lipoma arborescens 1
Elastofibroma dorsi 1
Glomus tumor 1
Desmoid 1
Total 31
b. Incorrect diagnosis by referring center; correct second opinion report
Tumor-like lesion 5
PVNS 2
Neurogenic tumor 1
Hemangioma 1
Nora’s lesion 1
Desmoid 1
Myxoma 1
Angioleiomyoma 1
Lipoma 1
Fibrous hamartoma 1
Total 15
c. Correct diagnosis by referring center; incorrect second opinion
report
Fibroma tendon sheath 1
Schwannoma 1
Total 2
d. Incorrect diagnosis by both referring center and second opinion
report
Lipoma 4
Tumor-like lesion 2
Neurogenic tumor 2
Desmoid 2
Chondroma 1
Hibernoma 1
Fibrous histiocytoma 1
Granular cell tumor 1
Lymphangioma 1
Hemangioma 1
Total 16
Table 4 Results of grading on MRI in group 1
Malignant Benign Total
a. Results of grading on MRI by expert center
MRI malignant 26 7 33
MRI benign 0 57 57
Total 26 64 90
b. Results of grading on MRI by referring center
MRI malignant 23 12 35
MRI benign 3 52 55
Total 26 64 90
a: Sensitivity 100%; specificity 89%; accuracy 92%
b Sensitivity 88%; specificity 81%; accuracy 83%
Table 5 List of lesions
without histopathologi-
cal proof but with con-
cordant MR diagnosis
(N051)
Histology Number
Hemangioma 16
Lipoma 11
Tumor-like lesion 8
Plantar fibromatosis 4
Neurogenic tumor 3
Elastofibroma 3
Morton’s fibroma 2
Ganglion cyst 2
Soft tissue metastasis 1
Giant cell tumor tendon
sheath
1
Total 51
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remains “indeterminate” [18], a number of unnecessary biop-
sies are unavoidable. Typical lesions that may be misinter-
preted as a malignant tumor are desmoid tumors because of
their aggressive growth pattern onimaging[19–21].Anumber
of lipomatous tumors may be misinterpreted as potential ma-
lignant lesions because they contain nonlipomatous compo-
nents. Gaskin et al. already stated that when an extremity or
bodywalllesionisconsideredsuggestiveofwell-differentiated
liposarcoma, 64% of these lesions will turn out to represent
benign lipoma variants containing nonlipomatous elements
[22]. In our series, four histopathologically proven lipomas
and one hibernoma were initially interpreted as well-
differentiated liposarcoma, because of lesion inhomogeneity
and intralesional nonlipomatous components. Recently,
Toirkens et al. confirmed that subcutaneous lipoma variants
and liposarcoma variants may show overlapping MR charac-
teristics [23]. Even in retrospect, these false-positive diagno-
ses may be unavoidable, but when a lipoma has to be
differentiated from a well-differentiated liposarcoma, there is
no change in the treatment regime, as both tumors are treated
by simple a shell-out procedure. In the group of histopatho-
logically proven tumors (group 1 of our series), the EC per-
formed better than the RC in suggesting a correct TS
diagnosis. This is also attributed to the increased knowledge
and experience with rare phenotypes of STTin the EC, which
were previously studied in case reports, review articles and
small series [19, 24–27].
Our study also confirms previous published data showing
that prediction of the TS diagnosis on MRI is more accurate
for benign than malignant STTs. In 2004, Gielen et al.
reported that a correct tissue-specific diagnosis of benign
STT could be predicted on MRI in 50% of cases [5]. A
slightly higher percentage (58%) was reported by Berquist
et al. [7]. In our series, the TS diagnosis was correct in 50%
of malignant lesions in the EC versus 38.5% in the RC. The
TS diagnosis was correct in 71.8% in the EC versus 51.6%
in the RC.
Among the 65 soft tissue lesions without histopathological
proof (Table 6), a concordant tissue-specific MR diagnosis
was made by both centers in the majority of cases (78.5%).
These cases presented with a typical MRI appearance such as
hemangioma, lipoma, etc. Concordance in the MR diagnosis
was extremely valuable for the referring physician, as it
allowed a more confident diagnosis based on the combination
of clinical findings and imaging. Aggressive diagnostic proce-
duresandtreatmentregimescouldbeavoidedinthesepatients,
and a reliable wait-and see policy could be implemented.
We acknowledge the limitations of our study.
First,therewasarelativelyhighnumberofmalignantSTTs
in our series (n026, 16.8%) compared to the estimated prev-
alence between 5.1 and 15.5% in the literature [28]. This may
be due to a selection bias caused by the referral policy by the
clinician for an MR examination. A second limitation is the
potential pathology bias. The pathologist was aware of the
imaging diagnosis of both centers when making his final
histopathological diagnosis, which might bias the pathologist
in the diagnosis of STT [29]. A third limitation is the high
numberofnon-histologicallyprovenSTTs(N065).However,
because of the evidence of benignity based on a combination
of imaging, clinical findings and follow-up, it would have not
been considered good medical practice if these patients had
undergone invasive diagnostic procedures. The last limitation
is due to the fact that the MR protocol was not completely
uniform as intravenous administration of gadolinium chelates
was not performed in all patients.
In conclusion, a second opinion imaging report by an
expert center is useful to enhance the overall accuracy in
diagnosis.
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